SCHEMBL7872006

SCHEMBL7872006

CC(C)(C)OC(=O)N1CCC(CSCc2ccccc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.58
PKM P14618 1/20 0.58
SMN1; SMN2 Q16637 2/20 0.57
GAA P10253 1/20 0.57
THRB P10828 1/20 0.57
STS P08842 1/20 0.55
GPR119 Q8TDV5 5/20 0.54
KEAP1 Q14145 1/20 0.49
NFE2L2 Q16236 1/20 0.49
JAK2 O60674 1/20 0.49
JAK1 P23458 1/20 0.49
YAP1 P46937 3/20 0.48
TGFBR1 P36897 1/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8644404 0.93 KDM4E (0.53) KDM4EPKMSMN1; SMN2GAATHRB
SCHEMBL27633116 0.87 ALDH1A1 (0.57) KDM4EPKMSMN1; SMN2STSGPR119
SCHEMBL6058749 0.84 KDM4E (0.52) KDM4EPKMSMN1; SMN2GAATHRB
SCHEMBL3123967 0.84 GAA (0.60) KDM4EPKMSMN1; SMN2GAATHRB
SCHEMBL3923737 0.83 KDM4E (0.64) KDM4EPKMSTSGPR119LMNA
SCHEMBL4248138 0.82 KDM4E (0.60) KDM4EPKMSMN1; SMN2GAATHRB
SCHEMBL1912705 0.82 KDM4E (0.62) KDM4EPKMSMN1; SMN2GAATHRB
SCHEMBL8781628 0.81 BRD3 (0.45) KDM4EPKMSMN1; SMN2GAATHRB
SCHEMBL8644744 0.81 BRD3 (0.45) KDM4EPKMSMN1; SMN2GAATHRB
SCHEMBL13913655 0.80 KDM4E (0.60) KDM4EPKMSMN1; SMN2GAATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US disclosed
WO-2000051608-A1 3-THIENYL AND 3-FURANYL PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed